Multifactorial ERβ and NOTCH1 control of squamous differentiation and cancer

Journal of Clinical Investigation

Volumn 124, Issue 5, 2014, Pages 2260-2276

  Brooks, Yang Sui ^a,b   Ostano, Paola ^c   Jo, Seung Hee ^a,b   Dai, Jun ^a,b   Getsios, Spiro ^d   Dziunycz, Piotr ^e   Hofbauer, Günther F L ^e   Cerveny, Kara ^f   Chiorino, Giovanna ^c   Lefort, Karine ^g,h   Dotto, G Paolo ^a,g  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c Laboratory of Cancer Genomics   (Italy)

^d NORTHWESTERN UNIVERSITY   (United States)

^e UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^f REED COLLEGE   (United States)

^g UNIVERSITY OF LAUSANNE   (Switzerland)

^h LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

EARLY GROWTH RESPONSE FACTOR 3; ESTROGEN RECEPTOR BETA; NOTCH1 RECEPTOR; RNA POLYMERASE II; TRANSCRIPTION FACTOR DLX5;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CELL MATURATION; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; GENE CONTROL; GENE EXPRESSION; GENE LOCUS; GENETIC TRANSCRIPTION; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; KERATINOCYTE; LOSS OF FUNCTION MUTATION; LUNG SQUAMOUS CELL CARCINOMA; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SKIN CARCINOMA; SQUAMOUS CELL; TUMOR XENOGRAFT;

ANIMALS; CARCINOMA, SQUAMOUS CELL; CELL DIFFERENTIATION; CELL LINE, TUMOR; ESTROGEN RECEPTOR BETA; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC LOCI; HEAD AND NECK NEOPLASMS; HETEROGRAFTS; HUMANS; LUNG NEOPLASMS; MALE; MICE; MICE, INBRED NOD; MICE, SCID; NEOPLASM PROTEINS; NEOPLASM TRANSPLANTATION; RECEPTOR, NOTCH1; RNA POLYMERASE II; TRANSCRIPTION, GENETIC;

EID: 84899761770     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI72718     Document Type: Article

References (68)

1. Kopan R, Ilagan MX. The canonical Notch signaling pathway: unfolding the activation mechanism. Cell. 2009;137(2):216-233.
2. Lefort K, Dotto GP. Notch signaling in the integrated control of keratinocyte growth/differentiation and tumor suppression. Semin Cancer Biol. 2004;14(5):374-386.
3. Agrawal N, et al. Exome sequencing of head and neck squamous cell carcinoma reveals inactivating mutations in NOTCH1. Science. 2011; 333(6046):1154-1157.
4. Agrawal N, et al. Comparative genomic analysis of esophageal adenocarcinoma and squamous cell carcinoma. Cancer Discov. 2012;2(10):899-905.
5. Hammerman PS, et al. Comprehensive genomic characterization of squamous cell lung cancers. Nature. 2012;489(7417):519-525.
6. Stransky N, et al. The mutational landscape of head and neck squamous cell carcinoma. Science. 2011;333(6046):1157-1160.
7. Wang NJ, et al. Loss-of-function mutations in Notch receptors in cutaneous and lung squamous cell carcinoma. Proc Natl Acad Sci U S A. 2011;108(43):17761-17766.
8. Dotto GP. Notch tumor suppressor function. Oncogene. 2008;27(38):5115- 5123.
9. Aster JC, Blacklow SC, Pear WS. Notch signalling in T-cell lymphoblastic leukaemia/lymphoma and other haematological malignancies. J Pathol. 2011;223(2):262-273.
10. Guo S, Liu M, Gonzalez-Perez RR. Role of Notch and its oncogenic signaling crosstalk in breast cancer. Biochim Biophys Acta. 2011;1815(2):197- 213.
11. Lefort K, et al. Notch1 is a p53 target gene involved in human keratinocyte tumor suppression through negative regulation of ROCK1/2 and MRCK kinases. Genes Dev. 2007;21(5):562-577.
12. Yugawa T, Handa K, Narisawa-Saito M, Ohno S, Fujita M, Kiyono T. Regulation of Notch1 gene expression by p53 in epithelial cells. Mol Cell Biol. 2007;27(10):3732-3742.
13. Gomez-del Arco P, et al. Alternative promoter usage at the Notch1 locus supports ligand-independent signaling in T cell development and leukemogenesis. Immunity. 2010;33(5):685-698.
14. Lambertini C, Pantano S, Dotto GP. Differential control of Notch1 gene transcription by Klf4 and Sp3 transcription factors in normal versus cancerderived keratinocytes. PLoS One. 2010;5(4):e10369.
15. Yang Y, et al. Loss of transcription factor KLF5 in the context of p53 ablation drives invasive progression of human squamous cell cancer. Cancer Res. 2011;71(20):6475-6484.
16. Wells J, et al. Ovol2 suppresses cell cycling and terminal differentiation of keratinocytes by directly repressing c-Myc and Notch1. J Biol Chem. 2009;284(42):29125-29135.
17. Cai J, Lee J, Kopan R, Ma L. Genetic interplays between Msx2 and Foxn1 are required for Notch1 expression and hair shaft differentiation. Dev Biol. 2009;326(2):420-430.
18. Cao F, Hata R, Zhu P, Nakashiro K, Sakanaka M. Conditional deletion of Stat3 promotes neurogenesis and inhibits astrogliogenesis in neural stem cells. Biochem Biophys Res Commun. 2010;394(3):843-847.
19. Yashiro-Ohtani Y, et al. Pre-TCR signaling inactivates Notch1 transcription by antagonizing E2A. Genes Dev. 2009;23(14):1665-1676.
20. Bedogni B, Warneke JA, Nickoloff BJ, Giaccia AJ, Powell MB. Notch1 is an effector of Akt and hypoxia in melanoma development. J Clin Invest. 2008;118(11):3660-3670.
21. Panganiban G, Rubenstein JL. Developmental functions of the Distal-less/Dlx homeobox genes. Development. 2002;129(19):4371-4386.
22. Tourtellotte WG, Milbrandt J. Sensory ataxia and muscle spindle agenesis in mice lacking the transcription factor Egr3. Nat Genet. 1998;20(1):87-91.
23. Heldring N, et al. Estrogen receptors: how do they signal and what are their targets. Physiol Rev. 2007;87(3):905-931.
24. Nilsson S, Gustafsson JA. Estrogen receptors: therapies targeted to receptor subtypes. Clin Pharmacol Ther. 2011;89(1):44-55.
25. Magnani L, et al. Genome-wide reprogramming of the chromatin landscape underlies endocrine therapy resistance in breast cancer. Proc Natl Acad Sci U S A. 2013;110(16):E1490-E1499.
26. Rizzo P, et al. Cross-talk between notch and the estrogen receptor in breast cancer suggests novel therapeutic approaches. Cancer Res. 2008; 68(13):5226-5235.
27. Grober OM, et al. Global analysis of estrogen receptor beta binding to breast cancer cell genome reveals an extensive interplay with estrogen receptor alpha for target gene regulation. BMC Genomics. 2011;12:36.
28. Chan KS, et al. Disruption of Stat3 reveals a critical role in both the initiation and the promotion stages of epithelial carcinogenesis. J Clin Invest. 2004;114(5):720-728.
29. Van Dyck F, Declercq J, Braem CV, Van de Ven WJ. PLAG1, the prototype of the PLAG gene family: versatility in tumour development (review). Int J Oncol. 2007;30(4):765-774.
30. Schmalhofer O, Brabletz S, Brabletz T. E-cadherin, beta-catenin, and ZEB1 in malignant progression of cancer. Cancer Metastasis Rev. 2009;28(1-2):151- 166.
31. Li G, et al. Extensive promoter-centered chromatin interactions provide a topological basis for transcription regulation. Cell. 2012;148(1-2):84-98.
32. Adelman K, Lis JT. Promoter-proximal pausing of RNA polymerase II: emerging roles in metazoans. Nat Rev Genet. 2012;13(10):720-731.
33. Nickoloff B, Qin J, Chaturvedi V, Denning M, Bonish B, Miele L. Jagged-1 mediated activation of notch signaling induces complete maturation of human keratinocytes through NF-B and PPAR?. Cell Death Differ. 2002;9(8):842-855.
34. Lefort K, et al. A miR-34a-SIRT6 axis in the squamous cell differentiation network. EMBO J. 2013;32(16):2248-2263.
35. Iso T, Kedes L, Hamamori Y. HES and HERP families: multiple effectors of the Notch signaling pathway. J Cell Physiol. 2003;194(3):237-255.
36. Itoh F, et al. Synergy and antagonism between Notch and BMP receptor signaling pathways in endothelial cells. EMBO J. 2004;23(3):541-551.
37. Lefort K, et al. A miR-34a-SIRT6 axis in the squamous cell differentiation network. EMBO J. 2013;32(16):2248-2263.
38. Revollo JR, Oakley RH, Lu NZ, Kadmiel M, Gandhavadi M, Cidlowski JA. HES1 is a master regulator of glucocorticoid receptor-dependent gene expression. Sci Signal. 2013;6(304):ra103.
39. Magnani L, Ballantyne EB, Zhang X, Lupien M. PBX1 genomic pioneer function drives ER signaling underlying progression in breast cancer. PLoS Genet. 2011;7(11):e1002368.
40. Burns KA, Korach KS. Estrogen receptors and human disease: an update. Arch Toxicol. 2012; 86(10):1491-1504.
41. Wu X, et al. Opposing roles for calcineurin and ATF3 in squamous skin cancer. Nature. 2010; 465(7296):368-372.
42. Harrington WR, Sheng S, Barnett DH, Petz LN, Katzenellenbogen JA, Katzenellenbogen BS. Activities of estrogen receptor alpha- and beta-selective ligands at diverse estrogen responsive gene sites mediating transactivation or transrepression. Mol Cell Endocrinol. 2003;206(1-2):13-22.
43. Dowsett M, Nicholson RI, Pietras RJ. Biological characteristics of the pure antiestrogen fulvestrant: overcoming endocrine resistance. Breast Cancer Res Treat. 2005;93(suppl 1):S11-S18.
44. Nishida CR, Everett S, Ortiz de Montellano PR. Specificity determinants of CYP1B1 estradiol hydroxylation. Mol Pharmacol. 2013;84(3):451-458.
45. O'Donovan KJ, Tourtellotte WG, Millbrandt J, Baraban JM. The EGR family of transcriptionregulatory factors: progress at the interface of molecular and systems neuroscience. Trends Neurosci. 1999;22(4):167-173.
46. Gomez-Martin D, Diaz-Zamudio M, Galindo-Campos M, Alcocer-Varela J. Early growth response transcription factors and the modulation of immune response: implications towards autoimmunity. Autoimmun Rev. 2010;9(6):454-458.
47. Guinea-Viniegra J, et al. Differentiation-induced skin cancer suppression by FOS, p53, and TACE/ ADAM17. J Clin Invest. 2012;122(8):2898-2910.
48. Abate-Shen C. Deregulated homeobox gene expression in cancer: cause or consequence? Nat Rev Cancer. 2002;2(10):777-785.
49. Lo Iacono N, et al. Regulation of Dlx5 and Dlx6 gene expression by p63 is involved in EEC and SHFM congenital limb defects. Development. 2008;135(7):1377-1388.
50. Morasso MI, Markova NG, Sargent TD. Regulation of epidermal differentiation by a Distal-less homeodomain gene. J Cell Biol. 1996;135(6 pt 2):1879-1887.
51. Hwang J, Mehrani T, Millar SE, Morasso MI. Dlx3 is a crucial regulator of hair follicle differentiation and cycling. Development. 2008;135(18):3149-3159.
52. Jackson B, et al. TALE homeodomain proteins regulate site-specific terminal differentiation, LCE genes and epidermal barrier. J Cell Sci. 2011; 124(pt 10):1681-1690.
53. Thornton MJ, et al. Oestrogen receptor beta is the predominant oestrogen receptor in human scalp skin. Exp Dermatol. 2003;12(2):181-190.
54. Fullwood MJ, et al. An oestrogen-receptor bound human chromatin interactome. Nature. 2009;462(7269):58-64.
55. Mitra P, Pereira LA, Drabsch Y, Ramsay RG, Gonda TJ. Estrogen receptor-alpha recruits P-TEFb to overcome transcriptional pausing in intron 1 of the MYB gene. Nucleic Acids Res. 2012;40(13):5988-6000.
56. Kolev V, et al. EGFR signalling as a negative regulator of Notch1 gene transcription and function in proliferating keratinocytes and cancer. Nat Cell Biol. 2008;10(8):902-911.
57. Ishizumi T, McWilliams A, MacAulay C, Gazdar A, Lam S. Natural history of bronchial preinvasive lesions. Cancer Metastasis Rev. 2010;29(1):5-14.
58. National Cancer Institute. Surveillance, Epidemiology, and End Results Program Web site. http://seer. cancer.gov/. Accessed March 12, 2014.
59. Cho JL, Allanson M, Reeve VE. Oestrogen receptor- signalling protects against transplanted skin tumour growth in the mouse. Photochem Photobiol Sci. 2010;9(4):608-614.
60. Mancuso M, et al. Modulation of basal and squamous cell carcinoma by endogenous estrogen in mouse models of skin cancer. Carcinogenesis. 2009;30(2):340-347.
61. Chen Z, et al. Estrogen promotes benzo[a]pyreneinduced lung carcinogenesis through oxidative stress damage and cytochrome c-mediated caspase- 3 activation pathways in female mice. Cancer Lett. 2011;308(1):14-22.
62. Siegfried JM. Smoking out reproductive hormone actions in lung cancer. Mol Cancer Res. 2014;12(1):24-31.
63. Herbst RS, Heymach JV, Lippman SM. Lung cancer. N Engl J Med. 2008;359(13):1367-1380.
64. Schwartz AG, et al. Reproductive factors, hormone use, estrogen receptor expression and risk of non small-cell lung cancer in women. J Clin Oncol. 2007;25(36):5785-5792.
65. Schwartz AG, et al. Nuclear estrogen receptor in lung cancer: expression and survival differences by sex. Clin Cancer Res. 2005;11(20):7280-7287.
66. Skov BG, Fischer BM, Pappot H. Oestrogen receptor beta over expression in males with non-small cell lung cancer is associated with better survival. Lung Cancer. 2008;59(1):88-94.
67. Dai J, Brooks Y, Lefort K, Getsios S, Dotto GP. The retinoid-related orphan receptor ROR promotes keratinocyte differentiation via FOXN1. PLoS One. 2013;8(7):e70392.
68. Getsios S, et al. Desmoglein 1-dependent suppression of EGFR signaling promotes epidermal differentiation and morphogenesis. J Cell Biol. 2009;185(7):1243-1258.